Hemodynamic augmentation indicator

General Details:

Name:
Hemodynamic augmentation indicator
Steward:
NINDS
Definition:
Indicator of whether hemodynamic augmentation is being given to the subject/participant
Registration Status:
Qualified

Permissible Values:

Value Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Yes, specify Yes, specify Yes, specify
No No No

Designations:

Designation:
Hemodynamic augmentation indicator
Tags:
Designation:
Hemodynamic augmentation
Tags:
Question Text

Designations:

Definition:
Indicator of whether hemodynamic augmentation is being given to the subject/participant
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131

Identifiers:

Source:
NLM
Id:
m1DlnbOq0q7
Version:
1.1
Source:
NINDS
Id:
C54933
Version:
1
Source:
BRICS Variable Name
Id:
HemodynamicAugmentatnInd
Version: